Next Article in Journal
Perturbation-Based Modeling Unveils the Autophagic Modulation of Chemosensitivity and Immunogenicity in Breast Cancer Cells
Previous Article in Journal
Mass Spectrometry-Based Zebrafish Toxicometabolomics: A Review of Analytical and Data Quality Challenges
Previous Article in Special Issue
Quo Vadis Caenorhabditis elegans Metabolomics—A Review of Current Methods and Applications to Explore Metabolism in the Nematode
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Mitochondrial Prohibitin (PHB) Complex in C. elegans Metabolism and Ageing Regulation

by
Artur B. Lourenço
1,* and
Marta Artal-Sanz
1,2,*
1
Andalusian Centre for Developmental Biology (CABD), CSIC-Universidad Pablo de Olavide-Junta de Andalucía, Carretera de Utrera Km 1, 41013 Seville, Spain
2
Department of Molecular Biology and Biochemical Engineering, Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013 Seville, Spain
*
Authors to whom correspondence should be addressed.
Metabolites 2021, 11(9), 636; https://doi.org/10.3390/metabo11090636
Submission received: 31 July 2021 / Revised: 14 September 2021 / Accepted: 16 September 2021 / Published: 17 September 2021
(This article belongs to the Special Issue Caenorhabditis elegans Applied to Metabolism Research)

Abstract

:
The mitochondrial prohibitin (PHB) complex, composed of PHB-1 and PHB-2, is an evolutionarily conserved context-dependent modulator of longevity. This extremely intriguing phenotype has been linked to alterations in mitochondrial function and lipid metabolism. The true biochemical function of the mitochondrial PHB complex remains elusive, but it has been shown to affect membrane lipid composition. Recent work, using large-scale biochemical approaches, has highlighted a broad effect of PHB on the C. elegans metabolic network. Collectively, the biochemical data support the notion that PHB modulates, at least partially, worm longevity through the moderation of fat utilisation and energy production via the mitochondrial respiratory chain. Herein, we review, in a systematic manner, recent biochemical insights into the impact of PHB on the C. elegans metabolome.

1. Introduction

Prohibitin proteins are strongly conserved from yeast to humans [1] and are related to bacterial HflKC, with which they share functional similarities [2]. In eukaryotes, prohibitins form a large multimeric complex called the mitochondrial prohibitin (PHB) complex [1,3,4]. The PHB complex is composed of 12–16 PHB-1/PHB-2 heterodimers assembled in a ring-shaped-like structure in the inner mitochondrial membrane facing the intermembrane space (reviewed in [5]). Both PHB-1/-2 subunits are ubiquitously and abundantly expressed, and are interdependent for protein complex formation, as the absence of either one of them leads to the absence of the full PHB complex [1,3,6]. Despite decades of work by many laboratories, the molecular function of the PHB complex is far from being clarified. It has been proposed to function as a chaperone-like protein that holds and stabilises mitochondrial proteins (reviewed in [1]) and as a lipid scaffold-like protein [7,8]. Although more work is still needed to better clarify its exact molecular function, evidence is accumulating for a direct impact of the PHB complex on mitochondrial functionality. In the yeast Saccharomyces cerevisiae, knockdown of the PHB complex leads to defects in mitochondrial membrane potential and to changes in mitochondrial morphology without an observable growth phenotype [6,9]. In multicellular eukaryotes, however, the PHB complex is essential for survival [3,7]. In mice, the post-natal tissue-specific absence of PHB in neurons results in neurodegeneration [10], and in β cells, PHB ablation impairs metabolic mitochondrial function and glucose homeostasis, leading to severe diabetes [11]. Furthermore, loss of PHB in podocytes results in kidney failure [12], and ablation in Schwann cells causes demyelinating neuropathy [13]. The mitochondrial phenotypes observed in these tissues and in mouse embryonic fibroblasts (MEFs), upon PHB ablation, include altered mitochondrial morphology, distribution, and dynamics, as well as aberrant cristae morphology [7,10,11,12,13]. In the nematode C. elegans, the postembryonic RNAi depletion of the PHB complex affects mitochondrial ultrastructure in muscle cells [3]. Moreover, worm tissues that rely heavily on mitochondrial function are more susceptible to PHB loss [3,14]. For example, the PHB complex is essential for somatic and germline differentiation in the larval gonad, resulting in its depletion in decreased fertility or even complete sterility. In addition, postembryonic PHB depletion leads to developmental delay, reduced body size, and slowed pharyngeal pumping and defecation [3]. PHB proteins play an important role in mitochondrial quality control, and their depletion induces the mitochondrial unfolded protein response (UPRmt), a stress response mechanism that reduces mitochondrial stress [15]. Likewise, PHB senses mitochondrial stress, and treatments that induce the UPRmt increase PHB protein levels [1,3,16,17]. Importantly, PHB complex deregulation and mitochondrial dysfunction have been associated in different systems with physiological processes such as cancer, degenerative disorders, obesity, and ageing [18,19,20,21].
Ageing is a multifactorial process characterised by a progressive loss of functionality at the organelle, cellular, tissue, and organ levels that consequently will have an impact on the whole organism leading ultimately to death [22,23]. In recent decades, there has been a consistent trend of an increase in the world population age [24,25]. Massive changes in the age stratification structure of a country’s population necessary lead to economic, social, and health challenges [26,27]. Model organisms have been instrumental to shed light on the complex process of ageing and on age-related pathologies, leading to the identification of several conserved molecular pathways regulating ageing [23]. The insulin/insulin growth factor 1 (IGF-1) signalling pathway (IIS) is well conserved among species and a universal longevity regulator that was first identified to modulate ageing in C. elegans [28,29,30]. The IIS is activated by the binding of insulin-like peptides to its receptor, encoded by daf-2 in C. elegans. DAF-2 activates AGE-1, and the downstream kinases AKT-1, AKT-2 and SGK-1 [31,32,33,34]. Activation of these kinases results in the phosphorylation of the transcription factor DAF-16 which is retained in the cytoplasm [35,36,37]. Upon inhibition of the IIS cascade, DAF-16 is activated [37,38,39] and triggers the expression of a plethora of genes involved in the regulation of lifespan [40]. The nematode C. elegans is one of the premier model organisms on ageing research due to its short life cycle and lifespan, its small size and transparency, the ease of its laboratory maintenance, and genetic manipulation. Moreover, fundamental eukaryotic cell biology and biochemistry processes are largely conserved between C. elegans and humans, including a wide spectrum of metabolic genes covering core metabolic pathways [41,42,43,44,45]. In fact, this is of particular relevance considering that metabolic alterations associated with nutrient-sensing pathways and mitochondria are a hallmark of ageing [46,47].
Prohibitins regulate replicative life span in yeast [9], senescence in mammalian fibroblasts [48], and promote longevity in worms [49]. Several years ago, we postulated that the PHB complex influences longevity through its effects on mitochondrial metabolism [5]. Later, PHB was found to modulate ageing in a metabolic-state dependent-manner [49,50,51]. Specifically, knockdown of the PHB complex shortens the lifespan of otherwise wild-type worms, while it markedly extends the lifespan of a large variety of C. elegans mutants. These include transforming growth factor-beta (TGF-β) signalling mutants, mutants with altered fat metabolism, mitochondrial electron transport chain (ETC) mutants, dietary restricted animals, and the long-lived IIS receptor daf-2 mutants. Although biochemical data were largely lacking, the impact of PHB on longevity was suggested to be through the modulation of fat metabolism [49]. Since then, different analyses based on 1H NMR spectroscopy, liquid chromatography coupled with mass spectrometry (LC/MS), gas chromatography coupled with flame-ionisation detection (GC/FID), high-performance liquid chromatography (HPLC), and thin-layer chromatography (TLC) added extremely valuable molecular insights into the metabolic changes occurring in C. elegans upon PHB depletion in wild-type and IIS daf-2 mutants [52,53]. Herein, we review these findings to provide a concise and systematic overview of the more recent biochemical insights into the effect of PHB on ageing regulation while setting the foundations for future studies.

2. The PHB Complex and Lipid Metabolism

In C. elegans, the PHB complex modulates fat content, as assessed by different fixed and live staining methods [49]. However, the complexity of the lipidome [54,55] is far from being captured through fat visualisation using dyes, as each of them has its own limitations [42,56]. In C. elegans, up to 35% of the dry body mass is composed of lipids, including free fatty acids, phospholipids, and triglycerides [54,57,58]. Remarkably, PHB deficiency has a wide impact on the C. elegans lipidome [52,53].

2.1. PHB Modulates the Whole-Worm Fatty Acid Composition

PHB depletion alters fatty acid (FA) composition, as assessed by GC/FID analysis. The effect of PHB depletion on FA composition is visible in developing L4 larvae. However, at the young adult (YA) stage, these changes become more noticeable, suggesting a more pronounced effect during adulthood or the accumulated consequence of altered FA metabolism. Overall, there is a trend towards an increase in shorter and monounsaturated FAs with a concomitant decrease in larger and polyunsaturated FAs upon PHB depletion. Surprisingly, while FA composition is clearly different between wild-type and daf-2 mutants, the effect of PHB depletion on FA composition follows the same general trend in both genetic backgrounds—namely, an increase in the content of palmitoleic acid (C16:1), and a decrease of eicosapentaenoic acid (C20:5n3) and dihomo-γ-linolenic acid (C20:3n6) [53]. Previously, it was reported that the FA chain length and susceptibility to oxidation decreases sharply in long-lived mutants of the IIS pathway, correlating extremely well with the increased lifespan of these worms [59]. The lifespan increase that occurs in daf-2 and in PHB-depleted daf-2 mutants is accompanied by changes in the FA composition that overall follow this trend. However, the FA composition of PHB-depleted wild-type worms, which are short-lived, is altered in a similar fashion. Therefore, the whole-worm FA composition at the YA stage cannot, on its own, account for the effect of PHB on the worm’s longevity [53]. One possible explanation is that large changes in FA composition, which follow the same trend, mask other relevant changes in lifespan determination. Alternatively, the trend observed, although the same, might result from different contributions. For example, alterations in different cellular compartments and/or different lipid classes. In particular, alterations in lipids or lipid-related molecules implicated in ageing regulation, such as triglycerides (TAGs) or ascarosides [60,61,62]. Although purely speculative, the observed changes in FA metabolism could have an impact on ascaroside metabolism and, in this way, modulate ageing.

2.2. Sphingolipids and Glycerophospholipids Respond to PHB Depletion in a Genetic Background Dependent-Manner

An LC/MS analysis of whole worms at the YA stage identified many lipid species— namely, sphingolipids, such as sphingomyelin (SM) and ceramide (CER), and glycerophospholipids, such as phosphatidylcholine (PC) and phosphatidylethanolamine (PE), with an altered content in response to PHB deficiency and/or in response to daf-2 mutation [53]. Specifically, both the SM pool, which, in other organisms, is mainly localised to the outer leaflet of plasma membranes [54], and the CER pool, important as a structural membrane lipid and required for surveillance of mitochondrial function [63], decrease their abundance upon PHB depletion. Similarly, PC and PE pools decreased in response to PHB depletion. Curiously, while daf-2 also reduces the SM, CER, PC, and PE pools, PHB depletion in daf-2 mutants only perturbs the CER pool with a further decrease. Of relevance, young daf-2 mutants have much lower levels of PC + PE pool, compared to matching wild-types [53]. A complementary HPLC analysis of ageing worms showed that the glycerophospholipid pool of PC and PE, the two most abundant membrane lipids [64,65], is largely unaffected in PHB-depleted daf-2 mutants, while it decreases markedly in PHB-depleted animals [53]. The differential effects identified on a whole worm basis, both at the YA stage and during ageing, could reflect a differential impact on the lipid composition of different organelles. The lipid composition of mitochondrial membranes is essential for the proper structure and function of the organelles. Membrane lipid biosynthesis occurs in an intimate interaction between the endoplasmic reticulum (ER) and mitochondria, as well as between mitochondrial membranes (Figure 1) [66]. In yeast, PHB genetically interacts with genes modulating mitochondrial phospholipid biosynthesis, in particular cardiolipin (CL) and PE, affecting the distribution of CL and PE by clustering them at distinct sites of the internal mitochondrial membrane [8,67,68]. Additionally, in MEFs, PHB cooperates with the mitochondrial cochaperone DNAJC19, for which DNJ-21 is the worm homolog, in the remodelling of mitochondrial membrane phospholipids. Specifically, lack of PHB complexes alters CL acylation, while the transcriptional response of PHB deficient cells shows altered lipid metabolism, most prominently cholesterol [69]. The PHB complex has been, therefore, suggested to act as a membrane organiser affecting the distribution of mitochondrial membrane lipids [8,67,68,69].

2.3. PHB Depletion Strongly Alters the Triacylglycerides Pool

In worms, the PHB complex alters glycerolipids at the YA stage. As assessed by whole worm LC/MS analysis, and similar to daf-2 mutants [70,71], PHB depletion increases the content of the large majority of glycerolipids species, while further increasing diacylglyceride (DAG) and TAG pools in daf-2 mutants. Strikingly, PHB depletion increases, mostly, TAG species with a longer average chain length, while in daf-2 mutants, lack of PHB mostly increases TAG species with a shorter average chain length. Additionally, while PHB depletion increases TAGs irrespective of the average degree of unsaturation, the effect of knocking down PHB in daf-2 mutants is restricted to TAGs with a low average degree of unsaturation. The FA composition of the TAG pool of whole worms, separated by TLC, indicates that PHB-depleted animals have a reduced content of shorter monounsaturated FAs than PHB-depleted daf-2 mutants, which concomitantly have a higher content of longer saturated FAs. Opposite to the glycerophospholipid pool, the TAG pool in PHB-depleted animals increases during ageing, while in PHB-depleted daf-2 mutants, it is much less affected [53]. The TAG pool is modulated by PHB in an IIS-dependent manner, which suggests a differential balancing and mobilisation of the TAG pool during ageing (Figure 1).

2.4. PHB Deficiency Affects Different Lipid-Related Organelles

Lipid homeostasis within a cell is achieved through the dynamic interaction between different organelles such as mitochondrion, ER, lipid droplet (LD), and yolk particle (YP) [72,73,74,75,76]. Mitochondria are particularly tightly connected with the ER but also with LDs [72,75,76]. In the worm’s intestine, neutral fat is accumulated in LDs, ubiquitous fat storage organelles, which are then mobilised according to the organism’s needs for membrane synthesis and energy [77,78]. Interestingly, in young animals PHB and DAF-2 affect LDs homeostasis differently, compared to wild-type animals, daf-2 mutants have higher LD intestinal coverage, whereas there is a much weaker effect in PHB-depleted animals. Strikingly, PHB depletion in daf-2 mutants synergistically increases the LD intestinal coverage of larger LDs [53]. Consistently, protein levels of ATGL-1, the worm homolog of the mammalian rate-limiting lipolytic enzyme ATGL and required for daf-2 longevity [79], are higher in wild-type worms than in daf-2 mutants during ageing. Moreover, while PHB depletion does not affect ATGL-1 levels in wild-type animals, it consistently further lowers ATGL-1 levels in daf-2 mutants. In parallel, PHB depletion differentially deregulates yolk homeostasis in wild-type and in daf-2 mutants [53]. YPs, produced through vitellogenesis, carry lipids such as TAGs and PLs to the gonad, where they are taken up by developing oocytes. Particularly during the reproductive period, vitellogenesis has a major impact on lipid homeostasis [80,81,82,83,84,85]. The PHB complex is essential for germline function, and its depletion leads to sterility [3]. Maybe as a consequence, PHB depletion accumulates large amounts of displaced yolk through the worm body during ageing. Strikingly, PHB-induced yolk accumulation is suppressed by daf-2 in aged worms (Figure 1). The ER is involved in the formation of LDs [86,87] and of YPs [88]. Mitochondrial contacts with the rough ER are important for lipoprotein secretion and systemic lipid homeostasis [88,89]. Importantly, PHB genetically interacts with genes involved in mitochondria-ER contact sites [90]. Interestingly, PHB depletion disrupts ER homeostasis, as assessed by a UPRER stress reporter, suggesting deregulation in the interaction between mitochondria and ER [53]. A recent publication shows that mitochondrial dysfunction caused by PHB deficiency leads to ER stress in Schwann cells of conditional knockout mice [13]. Curiously, daf-2 mutants are protected against ER stress, which has been linked to its longevity phenotype [91,92]. Indeed, while PHB depletion induces ER stress in otherwise wild-type worms, daf-2 mutant animals are protected, providing a plausible link between the ER and the PHB complex in ageing determination (Figure 1) [53].

3. PHB Has a Broad Impact on the C. elegans Metabolome

The metabolic effect of PHB depletion is not restricted to fat but has a much broader effect on the metabolic network [52]. Indeed, the 1H NMR metabolic profiles of whole worm extracts show the same general patterns evidenced by lipid analyses—namely, the metabolic changes due to PHB depletion become more pronounced throughout development. Strikingly, the metabolic profiles at the YA stage, reveal that PHB depletion has a stronger effect in wild-type animals than in daf-2 mutants. Specifically, the 1H NMR metabolic profiles uncover changes in carbohydrate and amino acid metabolism (Figure 1) [52].

3.1. PHB Adjusts the Content of Essential and Non-Essential Amino Acids

PHB depletion perturbs the abundance of a large spectrum of amino acids at the L4 and YA stages. At the YA stage, both, PHB deficiency and daf-2 mutation alter the content of amino acids, leading to PHB depletion in daf-2 mutants to a further readjustment of amino acid metabolism [52]. It has been described that supplementation of different amino acids can modulate C. elegans lifespan [2]. Interestingly, PHB depletion, specifically in otherwise wild-type animals, decreases the content of two branched-chain amino acids, leucine and valine, to the levels of daf-2 mutants, in which these changes are entirely DAF-16 dependent [93]. Although mild, wild-type worms have a higher content of alanine than daf-2 mutants. Strikingly, upon PHB depletion, alanine content is further increased in wild-type animals and further reduced in daf-2 mutants. Importantly, an inverse correlation between alanine levels and yeast chronological lifespan has been reported [94]. Similar to its effect on wild-type worms, PHB depletion in daf-2 mutants decreases the content of glutamate, while it increases the content of glutamine. Among other metabolic pathways, glutamate/glutamine metabolism is important for replenishing the tricarboxylic acid (TCA) cycle through their oxidative deamination [95]. Curiously, glutamate/glutamine metabolism has been described to be adjusted in impaired mitochondrial mutants with an altered lifespan [96]. The widespread impact of the PHB complex on amino acid metabolism (Figure 1), both in nutritionally essential and non-essential amino acids [97], reinforces the idea of a broad reorganisation of the metabolic network [52].

3.2. PHB Deficiency Rewires Carbohydrate and Energy Metabolism

Mitochondria are essential organelles in energy metabolism carrying out the TCA cycle and oxidative phosphorylation (OXPHOS) [98,99]. In mice, knockdown of liver PHB leads to an adjustment of whole-body energy homeostasis [100]. In aged worms, knockdown of PHB selectively increases oxygen consumption in daf-2, indicating that these worms sustain higher mitochondrial function in a long term [49]. PHB-depleted worms have a lower content of the TCA metabolite succinate, compared to wild-type animals, in line with the changes in TCA-related amino acids. Curiously, the amount of succinate is also reduced in daf-2 mutants but unaltered upon PHB depletion, which suggests that PHB adjusts the TCA cycle in wild-type animals but not in daf-2 mutants [52]. daf-2 mutants shift metabolism away from the TCA cycle towards the glyoxylate cycle [93,101,102]. The glyoxylate cycle is a variation of the TCA cycle that bypasses the decarboxylation steps and, among other things, enables the interconversion of fats and carbohydrates [103]. In C. elegans, endogenous glucose is stored in the form of trehalose, a non-reducing disaccharide, or glycogen, a branched polysaccharide [97]. Trehalose presumably acts as a stress protectant against multiple stresses [104,105,106,107,108,109] and as a longevity assurance sugar in C. elegans [107,110,111]. Although not to the same extent as daf-2 mutants, PHB depletion causes the accumulation of large amounts of trehalose. Interestingly, depleting PHB in a daf-2 mutant has an additive effect in trehalose accumulation [52]. Under a high sugar diet, shifting sugar storage from glycogen to trehalose promotes lifespan and health span in a DAF-16/FOXO-dependent manner. Specifically, lifespan increases as a result of high levels of internal trehalose through autophagy upregulation [111]. Moreover, trehalose supplementation from the YA stage significantly extends lifespan [107]. However, the requirement of trehalose for daf-2 longevity has been recently brought into question, because a deficiency in trehalose synthesis mildly shortened daf-2 lifespan [109], compared with previous studies [107,111]. Similar to trehalose supplementation, exogenous addition of lactate, which induces mitohormesis, leads to stress resistance and survival [112]. Lactate is an important bioenergetic metabolite formed either from fermentation or through aerobic glycolysis. Wild-type animals at the YA stage present larger amounts of lactate than daf-2 mutants. Moreover, similar to the effect on the pyruvate-related amino acid alanine, PHB depletion triggers an opposite effect on the content of lactate. While in otherwise wild-type animals, PHB depletion showed a trend to increase the content of lactate, in daf-2 mutants, PHB depletion showed a trend to decrease lactate content. This adjustment, as well as that of the pyruvate-related amino acid alanine, suggests a tuning of fermentative metabolism with possible implications in energy balance and longevity [52].

4. PHB-Mediated Ageing Regulation in a Metabolic Perspective

Mitochondrial function and metabolic homeostasis, crucial in ageing regulation [113], is severely disturbed by PHB depletion in a metabolic-state-dependent manner. Indeed, PHB depletion shortens the lifespan of wild-type animals, while enhancing the longevity of a plethora of metabolically compromised mutants, including targets of rapamycin complex 2 mutants sgk-1 and rict-1, and of the IIS receptor daf-2 mutants [49,50,114], linking PHB functions in mitochondria with cellular metabolism [2,31,52]. PHB deficiency also extends the lifespan of both, nhr-49 and fat-7 mutants [49]. NHR-49 is a key regulator of fat mobilisation, modulating fat consumption and maintaining a normal balance of FA saturation, while FAT-7 is required for the synthesis of monounsaturated fatty acids [115]. Collectively, our data suggest that the excess of TAGs accumulated in PHB-depleted daf-2 mutants is accommodated in larger intestinal LDs, which can be mobilised during ageing through tighter regulation of ATGL-1 (Figure 1) [53]. Cardiac fatty acid oxidation (FAO) is impaired in short-lived PHB2 cardiac-specific knockout mice through downregulation of carnitine palmitoyltransferase, a rate-limiting enzyme in mitochondrial FAO, [116]. Moreover, PHB deficient Schwann cells show reduced biosynthesis of fatty acids [13]. It would be interesting to investigate if these mechanisms are conserved in the nematode and whether they might be differentially regulated in daf-2 mutants, which could explain the differential effect of PHB in gut LDs. Importantly, yolk production, at the expense of the gut by a process of general autophagy, has been proposed as a major driver of worm senescence [117]. Lipotoxicity through ectopic yolk accumulation has been suggested to contribute to the opposing PHB ageing phenotype because PHB-induced yolk accumulation is suppressed by daf-2 in aged worms [53]. Interestingly, the specific depletion of PHB in mice hepatocytes causes a dramatic imbalance of lipid storage from adipose tissue to the liver [100]. We propose that PHB modulates yolk accumulation and TAG storage lipids in an IIS dependent-manner (Figure 1), reinforcing the connection between PHB and lipid metabolism in ageing regulation. Previously, PHB deficiency was shown to shorten the lifespan of aak-2 [49]. The AMP-dependent kinase AAK-2 has been implicated in coupling energy levels with signals from the IIS pathway to modulate lifespan in C. elegans [118,119]. The PHB complex is also important for mitochondrial DNA maintenance [120] and stabilisation of respiratory complexes and supercomplexes [121,122]. Strikingly, different OXPHOS mutants (gas-1, mev-1, and isp-1) also extend their lifespan upon PHB depletion [49]. The gas-1, mev-1, isp-1 genes encode subunits of the mitochondrial electron transport chain complexes I, II, and III, respectively, emphasising the importance of OXPHOS and PHB in lifespan regulation [53].
A key determinant of structural and functional integrity of eukaryotic membrane-bound organelles is membrane lipid composition [123,124]. As mentioned above, the PHB complex is important for mitochondrial membrane maintenance. Interestingly, depletion of DNJ-21, which physically and functionally interacts with PHB in remodelling mitochondrial cardiolipin, mimicked the differential effect of PHB deficiency on the lifespan of wild type and daf-2 mutants [53]. It would be interesting to investigate if DNJ-21 phenocopies other PHB phenotypes including effects on LD and YP, and lifespan extension in other metabolically compromised mutants. Importantly, reduced sphingolipid and ceramide synthesis extend the lifespan of worms and flies [125]. Recently, PHB was found to be required for the lifespan extension conferred by reduced sphingolipid synthesis in C. elegans. Moreover, in the same study, PHB depletion was found to suppress the impaired mitochondrial homeostasis, lipogenesis, and yolk formation of sgk-1 [114]. In summary, the PHB complex plays a crucial role in the determination of mitochondrial function by affecting, directly or indirectly, the maintenance and composition of mitochondrial membranes and by leading to systemic changes in metabolism, which ultimately, differentially modulate lifespan depending on the metabolic state of the animals (Figure 1).

5. Future Perspectives

Tremendous efforts have been made thus far to better characterise the effect of the PHB complex on the C. elegans metabolic network. Still, to give a more refined perspective on the broad metabolic alterations modulated by the PHB complex other levels of global data, such as RNA sequencing or proteomics data, would be extremely valuable. In the near future, it would be very interesting to assess the real relevance of several aspects raised so far to the PHB-mediated regulation of ageing—namely, the perturbation of mitochondrial membrane composition, the deregulation of yolk accumulation, the tight mobilisation of fat stores, and the balance of sugars storage. Specifically, it would be relevant to assess the role of yolk/lipoproteins on lifespan regulation and whether it is through vitellogenesis and/or ectopic yolk accumulation. Similarly, in the context of the positive impact of PHB depletion in the lifespan of daf-2 mutants, it would be interesting to determine whether increased availability of storage lipids and sugars and/or a more efficient mobilisation of these energy stores are relevant for lifespan regulation. Moreover, investigating the implication of peroxisomes would be relevant considering their implication on FAO and mitochondrial function in other life-extending paradigms [126]. Herein, we highlight some lines of research we are currently pursuing aimed at understanding the intriguing ageing phenotype of the PHB complex which is relevant to understand human ageing.

Author Contributions

A.B.L. and M.A.-S. wrote the manuscript. Both authors have read and agreed to the published version of the manuscript.

Funding

MA-S was supported by the Ramón y Cajal program of the Spanish Ministerio de Economía y Competitividad (RYC-2010-06167). Our work was supported by the European Research Council (ERC-2011-StG-281691).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Nijtmans, L.G.; De Jong, L.; Artal-Sanz, M.; Coates, P.; Berden, J.A.; Back, J.; Muijsers, A.O.; Van Der Spek, H.; Grivell, L.A. Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J. 2000, 19, 2444–2451. [Google Scholar] [CrossRef] [Green Version]
  2. Edwards, C.; Canfield, J.; Copes, N.; Brito, A.; Rehan, M.; Lipps, D.; Brunquell, J.; Westerheide, S.D.; Bradshaw, P.C. Mechanisms of amino acid-mediated lifespan extension in Caenorhabditis elegans. BMC Genet. 2015, 16, 8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Artal-Sanz, M.; Tsang, W.; Willems, E.M.; Grivell, L.A.; Lemire, B.D.; van der Spek, H.; Nijtmans, L.G.J. The Mitochondrial Prohibitin Complex Is Essential for Embryonic Viability and Germline Function in Caenorhabditis elegans. J. Biol. Chem. 2003, 278, 32091–32099. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Steglich, G.; Neupert, W.; Langer, T. Prohibitins Regulate Membrane Protein Degradation by the m -AAA Protease in Mitochondria. Mol. Cell. Biol. 1999, 19, 3435–3442. [Google Scholar] [CrossRef] [Green Version]
  5. Nijtmans, L.G.J.; Artal, S.M.; Grivell, A.L.; Coates, P.J. The mitochondrial PHB complex: Roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell. Mol. Life Sci. 2002, 59, 143–155. [Google Scholar] [CrossRef] [PubMed]
  6. Berger, K.H.; Yaffe, M.P. Prohibitin Family Members Interact Genetically with Mitochondrial Inheritance Components in Saccharomyces cerevisiae. Mol. Cell. Biol. 1998, 18, 4043–4052. [Google Scholar] [CrossRef] [Green Version]
  7. Merkwirth, C.; Dargazanli, S.; Tatsuta, T.; Geimer, S.; Löwer, B.; Wunderlich, F.T.; Von Kleist-Retzow, J.-C.; Waisman, A.; Westermann, B.; Langer, T. Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev. 2008, 22, 476–488. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Osman, C.; Haag, M.; Potting, C.; Rodenfels, J.; Dip, P.V.; Wieland, F.T.; Brügger, B.; Westermann, B.; Langer, T. The genetic interactome of prohibitins: Coordinated control of cardiolipin and phosphatidylethanolamine by conserved regulators in mitochondria. J. Cell Biol. 2009, 184, 583–596. [Google Scholar] [CrossRef] [Green Version]
  9. Coates, P.; Jamieson, D.; Smart, K.; Prescott, A.; Hall, P. The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr. Biol. 1997, 7, 607–610. [Google Scholar] [CrossRef] [Green Version]
  10. Merkwirth, C.; Martinelli, P.; Korwitz, A.; Morbin, M.; Brönneke, H.S.; Jordan, S.D.; Rugarli, E.; Langer, T. Loss of Prohibitin Membrane Scaffolds Impairs Mitochondrial Architecture and Leads to Tau Hyperphosphorylation and Neurodegeneration. PLoS Genet. 2012, 8, e1003021. [Google Scholar] [CrossRef] [Green Version]
  11. Supale, S.; Thorel, F.; Merkwirth, C.; Gjinovci, A.; Herrera, P.L.; Scorrano, L.; Meda, P.; Langer, T.; Maechler, P. Loss of prohibitin induces mitochondrial damages altering beta-cell function and survival and is responsible for gradual diabetes development. Diabetes 2013, 62, 3488–3499. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Ising, C.; Koehler, S.; Brähler, S.; Merkwirth, C.; Höhne, M.; Baris, O.R.; Hagmann, H.; Kann, M.; Fabretti, F.; Dafinger, C.; et al. Inhibition of insulin/IGF-1 receptor signaling protects from mitochondria-mediated kidney failure. EMBO Mol. Med. 2015, 7, 275–287. [Google Scholar] [CrossRef] [PubMed]
  13. Nunes, G.D.-F.; Wilson, E.R.; Marziali, L.N.; Hurley, E.; Silvestri, N.; He, B.; O’Malley, B.W.; Beirowski, B.; Poitelon, Y.; Wrabetz, L.; et al. Prohibitin 1 is essential to preserve mitochondria and myelin integrity in Schwann cells. Nat. Commun. 2021, 12, 3285. [Google Scholar] [CrossRef]
  14. Artal-Sanz, M.; Tavernarakis, N. Prohibitin and mitochondrial biology. Trends Endocrinol. Metab. 2009, 20, 394–401. [Google Scholar] [CrossRef] [Green Version]
  15. Hernando-Rodríguez, B.; Artal-Sanz, M. Mitochondrial Quality Control Mechanisms and the PHB (Prohibitin) Complex. Cells 2018, 7, 238. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Nijtmans, L.; Sanz, M.A.; Bucko, M.; Farhoud, M.; Feenstra, M.; Hakkaart, G.; Zeviani, M.; Grivell, L. Shy1p occurs in a high molecular weight complex and is required for efficient assembly of cytochrome c oxidase in yeast. FEBS Lett. 2001, 498, 46–51. [Google Scholar] [CrossRef] [Green Version]
  17. Zhang, H.; Ryu, D.; Wu, Y.; Gariani, K.; Wang, X.; Luan, P.; D’Amico, D.; Ropelle, E.R.; Lutolf, M.P.; Aebersold, R.; et al. NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science 2016, 352, 1436–1443. [Google Scholar] [CrossRef] [Green Version]
  18. Ande, S.R.; Nguyen, K.H.; Padilla-Meier, G.P.; Wahida, W.; Nyomba, B.G.; Mishra, S. Prohibitin Overexpression in Adipocytes Induces Mitochondrial Biogenesis, Leads to Obesity Development, and Affects Glucose Homeostasis in a Sex-Specific Manner. Diabetes 2014, 63, 3734–3741. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Koushyar, S.; Jiang, W.G.; Dart, D.A. Unveiling the potential of prohibitin in cancer. Cancer Lett. 2015, 369, 316–322. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Thuaud, F.; Ribeiro, N.; Nebigil, C.G.; Désaubry, L. Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential. Chem. Biol. 2013, 20, 316–331. [Google Scholar] [CrossRef] [Green Version]
  21. Huang, H.; Zhang, S.; Li, Y.; Liu, Z.; Mi, L.; Cai, Y.; Wang, X.; Chen, L.; Ran, H.; Xiao, D.; et al. Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance. Nat. Commun. 2021, 12, 3720. [Google Scholar] [CrossRef] [PubMed]
  22. Partridge, L.; Deelen, J.; Slagboom, P.E. Facing up to the global challenges of ageing. Nature 2018, 561, 45–56. [Google Scholar] [CrossRef]
  23. Taormina, G.; Ferrante, F.; Vieni, S.; Grassi, N.; Russo, A.; Mirisola, M.G. Longevity: Lesson from Model Organisms. Genes 2019, 10, 518. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Lloyd-Sherlock, P. Population ageing in developed and developing regions: Implications for health policy. Soc. Sci. Med. 2000, 51, 887–895. [Google Scholar] [CrossRef]
  25. Shetty, A.K.; Kodali, M.; Upadhya, R.; Madhu, L.N. Emerging Anti-Aging Strategies—Scientific Basis and Efficacy. Aging Dis. 2018, 9, 1165–1184. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Aunan, J.R.; Cho, W.C.; Søreide, K. The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks. Aging Dis. 2017, 8, 628–642. [Google Scholar] [CrossRef] [Green Version]
  27. Hou, Y.; Dan, X.; Babbar, M.; Wei, Y.; Hasselbalch, S.G.; Croteau, D.L.; Bohr, V.A. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 2019, 15, 565–581. [Google Scholar] [CrossRef]
  28. Blüher, M.; Kahn, B.B.; Kahn, C.R. Extended Longevity in Mice Lacking the Insulin Receptor in Adipose Tissue. Science 2003, 299, 572–574. [Google Scholar] [CrossRef] [Green Version]
  29. Kenyon, C.; Chang, J.; Gensch, E.; Rudner, A.; Tabtiang, R. A C. elegans mutant that lives twice as long as wild type. Nature 1993, 366, 461–464. [Google Scholar] [CrossRef]
  30. Tatar, M.; Kopelman, A.; Epstein, D.; Tu, M.-P.; Yin, C.-M.; Garofalo, R.S. A Mutant Drosophila Insulin Receptor Homolog That Extends Life-Span and Impairs Neuroendocrine Function. Science 2001, 292, 107–110. [Google Scholar] [CrossRef] [Green Version]
  31. Alessi, D.R.; Andjelkovic, M.; Caudwell, B.; Cron, P.; Morrice, N.; Cohen, P.; Hemmings, B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996, 15, 6541–6551. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Kobayashi, T.; Cohen, P. Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK. Biochem. J. 1999, 339, 319–328. [Google Scholar] [CrossRef]
  33. Park, J.; Leong, M.L.; Buse, P.; Maiyar, A.C.; Firestone, G.L.; Hemmings, B.A. Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J. 1999, 18, 3024–3033. [Google Scholar] [CrossRef] [Green Version]
  34. Stephens, L.; Anderson, K.; Stokoe, D.; Erdjument-Bromage, H.; Painter, G.F.; Holmes, A.B.; Gaffney, P.R.J.; Reese, C.B.; McCormick, F.; Tempst, P.; et al. Protein Kinase B Kinases That Mediate Phosphatidylinositol 3,4,5-Trisphosphate-Dependent Activation of Protein Kinase B. Science 1998, 279, 710–714. [Google Scholar] [CrossRef]
  35. Hertweck, M.; Göbel, C.; Baumeister, R. C. elegans SGK-1 Is the Critical Component in the Akt/PKB Kinase Complex to Control Stress Response and Life Span. Dev. Cell 2004, 6, 577–588. [Google Scholar] [CrossRef] [Green Version]
  36. Lee, R.; Hench, J.; Ruvkun, G. Regulation of C. elegans DAF-16 and its human ortholog FKHRL1 by the daf-2 insulin-like signaling pathway. Curr. Biol. 2001, 11, 1950–1957. [Google Scholar] [CrossRef] [Green Version]
  37. Lin, K.; Hsin, H.; Libina, N.; Kenyon, C. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat. Genet. 2001, 28, 139–145. [Google Scholar] [CrossRef]
  38. Henderson, S.T.; Johnson, T.E. daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr. Biol. 2001, 11, 1975–1980. [Google Scholar] [CrossRef] [Green Version]
  39. Ogg, S.; Paradis, S.; Gottlieb, S.; Patterson, G.I.; Lee, L.; Tissenbaum, H.A.; Ruvkun, G. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 1997, 389, 994–999. [Google Scholar] [CrossRef]
  40. Murphy, C.; McCarroll, S.; Bargmann, C.; Fraser, A.; Kamath, R.S.; Ahringer, J.; Li, H.; Kenyon, C. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 2003, 424, 277–283. [Google Scholar] [CrossRef]
  41. Kenyon, C.J. The genetics of ageing. Nature 2010, 464, 504–512. [Google Scholar] [CrossRef] [PubMed]
  42. Lemieux, G.A.; Ashrafi, K. Insights and challenges in using C. elegans for investigation of fat metabolism. Crit. Rev. Biochem. Mol. Biol. 2015, 50, 69–84. [Google Scholar] [CrossRef]
  43. Mullaney, B.C.; Ashrafi, K. C. elegans fat storage and metabolic regulation. Biochim. et Biophys. Acta (BBA)-Mol. Cell Biol. Lipids 2009, 1791, 474–478. [Google Scholar] [CrossRef] [Green Version]
  44. Shaye, D.D.; Greenwald, I. OrthoList: A Compendium of C. elegans Genes with Human Orthologs. PLoS ONE 2011, 6, e20085. [Google Scholar] [CrossRef] [PubMed]
  45. Sonnhammer, E.L.; Durbin, R. Analysis of Protein Domain Families in Caenorhabditis elegans. Genomics 1997, 46, 200–216. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Niccoli, T.; Partridge, L. Ageing as a Risk Factor for Disease. Curr. Biol. 2012, 22, R741–R752. [Google Scholar] [CrossRef] [Green Version]
  47. Toth, M.; Tchernof, A. Lipid metabolism in the elderly. Eur. J. Clin. Nutr. 2000, 54, S121–S125. [Google Scholar] [CrossRef] [PubMed]
  48. Coates, P.; Nenutil, R.; Mc Gregord, A.; Picksley, S.; Crouch, D.; Hall, P.; Wrightab, E.G. Mammalian Prohibitin Proteins Respond to Mitochondrial Stress and Decrease during Cellular Senescence. Exp. Cell Res. 2001, 265, 262–273. [Google Scholar] [CrossRef] [PubMed]
  49. Artal-Sanz, M.; Tavernarakis, N. Prohibitin couples diapause signalling to mitochondrial metabolism during ageing in C. elegans. Nature 2009, 461, 793–797. [Google Scholar] [CrossRef]
  50. Gatsi, R.; Schulze, B.; Rodríguez-Palero, M.J.; Hernando-Rodríguez, B.; Baumeister, R.; Artal-Sanz, M. Prohibitin-Mediated Lifespan and Mitochondrial Stress Implicate SGK-1, Insulin/IGF and mTORC2 in C. elegans. PLoS ONE 2014, 9, e107671. [Google Scholar] [CrossRef]
  51. Schleit, J.; Johnson, S.; Bennett, C.; Simko, M.; Trongtham, N.; Castanza, A.; Hsieh, E.J.; Moller, R.M.; Wasko, B.; Delaney, J.R.; et al. Molecular mechanisms underlying genotype-dependent responses to dietary restriction. Aging Cell 2013, 12, 1050–1061. [Google Scholar] [CrossRef] [Green Version]
  52. Lourenço, A.B.; Muñoz-Jiménez, C.; Venegas-Calerón, M.; Artal-Sanz, M. Analysis of the effect of the mitochondrial prohibitin complex, a context-dependent modulator of longevity, on the C. elegans metabolome. Biochim. et Biophys. Acta (BBA)-Bioenerg. 2015, 1847, 1457–1468. [Google Scholar] [CrossRef] [Green Version]
  53. Lourenço, A.B.; Rodríguez-Palero, M.J.; Doherty, M.K.; Granados, D.C.; Hernando-Rodríguez, B.; Salas, J.J.; Venegas-Calerón, M.; Whitfield, P.D.; Artal-Sanz, M. The Mitochondrial PHB Complex Determines Lipid Composition and Interacts with the Endoplasmic Reticulum to Regulate Ageing. Front. Physiol. 2021, 12, 696275. [Google Scholar] [CrossRef] [PubMed]
  54. Watts, J.L.; Ristow, M. Lipid and Carbohydrate Metabolism in Caenorhabditis elegans. Genetics 2017, 207, 413–446. [Google Scholar] [PubMed]
  55. Zhang, Y.; Zou, X.; Ding, Y.; Wang, H.; Wu, X.; Liang, B. Comparative genomics and functional study of lipid metabolic genes in Caenorhabditis elegans. BMC Genom. 2013, 14, 164. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Hellerer, T.; Axang, C.; Brackmann, C.; Hillertz, P.; Pilon, M.; Enejder, A. Monitoring of lipid storage in Caenorhabditis elegans using coherent anti-Stokes Raman scattering (CARS) microscopy. Proc. Natl. Acad. Sci. USA 2007, 104, 14658–14663. [Google Scholar] [CrossRef] [Green Version]
  57. Ashrafi, K. Mapping out starvation responses. Cell Metab. 2006, 3, 235–236. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. O’Rourke, E.J.; Soukas, A.A.; Carr, C.; Ruvkun, G. C. elegans Major Fats Are Stored in Vesicles Distinct from Lysosome-Related Organelles. Cell Metab. 2009, 10, 430–435. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Reis, R.J.S.; Xu, L.; Lee, H.; Chae, M.; Thaden, J.J.; Bharill, P.; Tazearslan, C.; Siegel, E.; Alla, R.; Zimniak, P.; et al. Modulation of lipid biosynthesis contributes to stress resistance and longevity of C. elegans mutants. Aging 2011, 3, 125–147. [Google Scholar] [CrossRef] [Green Version]
  60. Chung, K. Advances in Understanding of the Role of Lipid Metabolism in Aging. Cells 2021, 10, 880. [Google Scholar] [CrossRef]
  61. Hou, N.S.; Taubert, S. Function and Regulation of Lipid Biology in Caenorhabditis elegans Aging. Front. Physiol. 2012, 3, 143. [Google Scholar] [CrossRef] [Green Version]
  62. Park, J.Y.; Joo, H.-J.; Paik, Y.-K. Ascaroside Pheromones: Chemical Biology and Pleiotropic Neuronal Functions. Int. J. Mol. Sci. 2019, 20, 3898. [Google Scholar] [CrossRef] [Green Version]
  63. Liu, Y.; Samuel, B.; Breen, P.C.; Ruvkun, G. Caenorhabditis elegans pathways that surveil and defend mitochondria. Nature 2014, 508, 406–410. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Satouchi, K.; Hirano, K.; Sakaguchi, M.; Takehara, H.; Matsuura, F. Phospholipids from the free-living nematode Caenorhabditis elegans. Lipids 1993, 28, 837–840. [Google Scholar] [CrossRef] [PubMed]
  65. Vrablik, T.L.; Petyuk, V.; Larson, E.M.; Smith, R.D.; Watts, J.L. Lipidomic and proteomic analysis of Caenorhabditis elegans lipid droplets and identification of ACS-4 as a lipid droplet-associated protein. Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids 2015, 1851, 1337–1345. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Tatsuta, T.; Scharwey, M.; Langer, T. Mitochondrial lipid trafficking. Trends Cell Biol. 2014, 24, 44–52. [Google Scholar] [CrossRef]
  67. Birner, R.; Nebauer, R.; Schneiter, R.; Daum, G. Synthetic Lethal Interaction of the Mitochondrial Phosphatidylethanolamine Biosynthetic Machinery with the Prohibitin Complex of Saccharomyces cerevisiae. Mol. Biol. Cell 2003, 14, 370–383. [Google Scholar] [CrossRef] [Green Version]
  68. Klecker, T.; Wemmer, M.; Haag, M.; Weig, A.; Böckler, S.; Langer, T.; Nunnari, J.; Westermann, B. Interaction of MDM33 with mitochondrial inner membrane homeostasis pathways in yeast. Sci. Rep. 2015, 5, 18344. [Google Scholar] [CrossRef]
  69. Richter-Dennerlein, R.; Korwitz, A.; Haag, M.; Tatsuta, T.; Dargazanli, S.; Baker, M.; Decker, T.; Lamkemeyer, T.; Rugarli, E.; Langer, T. DNAJC19, a Mitochondrial Cochaperone Associated with Cardiomyopathy, Forms a Complex with Prohibitins to Regulate Cardiolipin Remodeling. Cell Metab. 2014, 20, 158–171. [Google Scholar] [CrossRef] [Green Version]
  70. Perez, C.L.; Van Gilst, M.R. A 13C Isotope Labeling Strategy Reveals the Influence of Insulin Signaling on Lipogenesis in C. elegans. Cell Metab. 2008, 8, 266–274. [Google Scholar] [CrossRef] [Green Version]
  71. Prasain, J.K.; Wilson, L.; Hoang, H.D.; Moore, R.; Miller, M.A. Comparative Lipidomics of Caenorhabditis elegans Metabolic Disease Models by SWATH Non-Targeted Tandem Mass Spectrometry. Metabolites 2015, 5, 677–696. [Google Scholar] [CrossRef] [Green Version]
  72. Diogo, C.V.; Yambire, K.F.; Mosquera, L.F.; Raimundo, N. Mitochondrial adventures at the organelle society. Biochem. Biophys. Res. Commun. 2017, 500, 87–93. [Google Scholar] [CrossRef] [PubMed]
  73. Ezcurra, M.; Benedetto, A.; Sornda, T.; Gilliat, A.F.; Au, C.; Zhang, Q.; van Schelt, S.; Petrache, A.L.; Wang, H.; de la Guardia, Y.; et al. C. elegans Eats Its Own Intestine to Make Yolk Leading to Multiple Senescent Pathologies. Curr. Biol. 2018, 28, 2544–2556.e5. [Google Scholar] [CrossRef] [PubMed]
  74. Gami, M.S.; Wolkow, C.A. Studies of Caenorhabditis elegans DAF-2/insulin signaling reveal targets for pharmacological manipulation of lifespan. Aging Cell 2006, 5, 31–37. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Nguyen, T.B.; Louie, S.M.; Daniele, J.R.; Tran, Q.; Dillin, A.; Zoncu, R.; Nomura, D.K.; Olzmann, J.A. DGAT1-Dependent Lipid Droplet Biogenesis Protects Mitochondrial Function during Starvation-Induced Autophagy. Dev. Cell 2017, 42, 9–21.e5. [Google Scholar] [CrossRef] [Green Version]
  76. Sugiura, A.; Mattie, S.; Prudent, J.; McBride, H.M. Newly born peroxisomes are a hybrid of mitochondrial and ER-derived pre-peroxisomes. Nat. Cell Biol. 2017, 542, 251–254. [Google Scholar] [CrossRef]
  77. Mak, H.Y. Lipid droplets as fat storage organelles in Caenorhabditis elegans: Thematic Review Series: Lipid Droplet Synthesis and Metabolism: From Yeast to Man. J. Lipid Res. 2012, 53, 28–33. [Google Scholar] [CrossRef] [Green Version]
  78. Olzmann, J.A.; Carvalho, P. Dynamics and functions of lipid droplets. Nat. Rev. Mol. Cell Biol. 2018, 20, 137–155. [Google Scholar] [CrossRef]
  79. Zaarur, N.; Desevin, K.; Mackenzie, J.; Lord, A.; Grishok, A.; Kandror, K.V. ATGL-1 mediates the effect of dietary restriction and the insulin/IGF-1 signaling pathway on longevity in C. elegans. Mol. Metab. 2019, 27, 75–82. [Google Scholar] [CrossRef]
  80. Grant, B.; Hirsh, D. Receptor-mediated Endocytosis in the Caenorhabditis elegans Oocyte. Mol. Biol. Cell 1999, 10, 4311–4326. [Google Scholar] [CrossRef] [Green Version]
  81. Heine, U.; Blumenthal, T. Characterization of regions of the Caenorhabditis elegans X chromosome containing vitellogenin genes. J. Mol. Biol. 1986, 188, 301–312. [Google Scholar] [CrossRef]
  82. Kimble, J.; Sharrock, W.J. Tissue-specific synthesis of yolk proteins in Caenorhabditis elegans. Dev. Biol. 1983, 96, 189–196. [Google Scholar] [CrossRef]
  83. Fukushige, T.; Hawkins, M.G.; McGhee, J.D. The GATA-factor elt-2 is essential for formation of the Caenorhabditis elegans intestine. Dev. Biol. 1998, 198, 286–302. [Google Scholar] [CrossRef] [Green Version]
  84. Sharrock, W.J.; Sutherlin, E.M.; Leske, K.; Cheng, T.K.; Kim, T.Y. Two distinct yolk lipoprotein complexes from Caenorhabditis elegans. J. Biol. Chem. 1990, 265, 14422–14431. [Google Scholar] [CrossRef]
  85. Spieth, J.; Blumenthal, T. The Caenorhabditis elegans vitellogenin gene family includes a gene encoding a distantly related protein. Mol. Cell. Biol. 1985, 5, 2495–2501. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Cao, Z.; Hao, Y.; Fung, C.W.; Lee, Y.Y.; Wang, P.; Li, X.; Xie, K.; Lam, W.J.; Qiu, Y.; Tang, B.Z.; et al. Dietary fatty acids promote lipid droplet diversity through seipin enrichment in an ER subdomain. Nat. Commun. 2019, 10, 2902. [Google Scholar] [CrossRef] [Green Version]
  87. Jacquemyn, J.; Cascalho, A.C.C.; Goodchild, E.R. The ins and outs of endoplasmic reticulum-controlled lipid biosynthesis. EMBO Rep. 2017, 18, 1905–1921. [Google Scholar] [CrossRef] [PubMed]
  88. Seah, N.E.; Petrashen, A.P.; Henderson, H.R.; Laguer, J.; Gonzalez, J.; Dillin, A.; Hansen, M.; Lapierre, L.R. Autophagy-mediated longevity is modulated by lipoprotein biogenesis. Autophagy 2016, 12, 261–272. [Google Scholar] [CrossRef] [Green Version]
  89. Anastasia, I.; Ilacqua, N.; Raimondi, A.; Lemieux, P.; Ghandehari-Alavijeh, R.; Faure, G.; Mekhedov, S.L.; Williams, K.J.; Caicci, F.; Valle, G.; et al. Mitochondria-rough-ER contacts in the liver regulate systemic lipid homeostasis. Cell Rep. 2021, 34, 108873. [Google Scholar] [CrossRef]
  90. Kornmann, B.; Currie, E.; Collins, S.R.; Schuldiner, M.; Nunnari, J.; Weissman, J.S.; Walter, P. An ER-Mitochondria Tethering Complex Revealed by a Synthetic Biology Screen. Science 2009, 325, 477–481. [Google Scholar] [CrossRef] [Green Version]
  91. Henis-Korenblit, S.; Zhang, P.; Hansen, M.; McCormick, M.; Lee, S.-J.; Cary, M.; Kenyon, C. Insulin/IGF-1 signaling mutants reprogram ER stress response regulators to promote longevity. Proc. Natl. Acad. Sci. USA 2010, 107, 9730–9735. [Google Scholar] [CrossRef] [Green Version]
  92. Zhou, K.; Pincus, Z.; Slack, F.J. Longevity and stress in Caenorhabditis elegans. Aging 2011, 3, 733–753. [Google Scholar] [CrossRef] [Green Version]
  93. Fuchs, S.; Bundy, J.G.; Davies, S.K.; Viney, J.M.; Swire, J.S.; Leroi, A.M. A metabolic signature of long life in Caenorhabditis elegans. BMC Biol. 2010, 8, 14. [Google Scholar] [CrossRef] [Green Version]
  94. Yu, S.-L.; An, Y.J.; Yang, H.-J.; Kang, M.-S.; Kim, H.-Y.; Wen, H.; Jin, X.; Kwon, H.N.; Min, K.-J.; Lee, S.-K.; et al. Alanine-Metabolizing Enzyme Alt1 Is Critical in Determining Yeast Life Span, As Revealed by Combined Metabolomic and Genetic Studies. J. Proteome Res. 2013, 12, 1619–1627. [Google Scholar] [CrossRef]
  95. Newsholme, P.; Procopio, J.; Lima, M.M.R.; Pithon-Curi, T.C.; Curi, R. Glutamine and glutamate? Their central role in cell metabolism and function. Cell Biochem. Funct. 2003, 21, 1–9. [Google Scholar] [CrossRef]
  96. Vergano, S.S.; Rao, M.; McCormack, S.; Ostrovsky, J.; Clarke, C.; Preston, J.; Bennett, M.J.; Yudkoff, M.; Xiao, R.; Falk, M.J. In vivo metabolic flux profiling with stable isotopes discriminates sites and quantifies effects of mitochondrial dysfunction in C. elegans. Mol. Genet. Metab. 2013, 111, 331–341. [Google Scholar] [CrossRef] [Green Version]
  97. Zečić, A.; Dhondt, I.; Braeckman, B.P. The nutritional requirements of Caenorhabditis elegans. Genes Nutr. 2019, 14, 15. [Google Scholar] [CrossRef]
  98. Cui, L.; Liu, P. Two Types of Contact between Lipid Droplets and Mitochondria. Front. Cell Dev. Biol. 2020, 8, 618322. [Google Scholar] [CrossRef] [PubMed]
  99. Tsang, W.Y.; Lemire, B.D. The role of mitochondria in the life of the nematode, Caenorhabditis elegans. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 2003, 1638, 91–105. [Google Scholar] [CrossRef] [Green Version]
  100. Li, L.; Martin-Levilain, J.; Jiménez-Sánchez, C.; Karaca, M.; Foti, M.; Martinou, J.-C.; Maechler, P. In vivo stabilization of OPA1 in hepatocytes potentiates mitochondrial respiration and gluconeogenesis in a prohibitin-dependent way. J. Biol. Chem. 2019, 294, 12581–12598. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  101. Ruzanov, P.; Riddle, D.L.; Marra, M.A.; McKay, S.J.; Jones, S.M. Genes that may modulate longevity in C. elegans in both dauer larvae and long-lived daf-2 adults. Exp. Gerontol. 2007, 42, 825–839. [Google Scholar] [CrossRef] [Green Version]
  102. Vanfleteren, J.R.; Braeckman, B.P. Mechanisms of life span determination in Caenorhabditis elegans. Neurobiol. Aging 1999, 20, 487–502. [Google Scholar] [CrossRef]
  103. Kunze, M.; Pracharoenwattana, I.; Smith, S.M.; Hartig, A. A central role for the peroxisomal membrane in glyoxylate cycle function. Biochim. Biophys. Acta (BBA)-Bioenerg. 2006, 1763, 1441–1452. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Chaudhary, R.K.; Kardani, J.; Singh, K.; Banerjee, R.; Roy, I. Deciphering the Roles of Trehalose and Hsp104 in the Inhibition of Aggregation of Mutant Huntingtin in a Yeast Model of Huntington’s Disease. NeuroMolecular Med. 2013, 16, 280–291. [Google Scholar] [CrossRef]
  105. Erkut, C.; Penkov, S.; Khesbak, H.; Vorkel, D.; Verbavatz, J.-M.; Fahmy, K.; Kurzchalia, T.V. Trehalose Renders the Dauer Larva of Caenorhabditis elegans Resistant to Extreme Desiccation. Curr. Biol. 2011, 21, 1331–1336. [Google Scholar] [CrossRef] [Green Version]
  106. Hedoux, A.; Paccou, L.; Achir, S.; Guinet, Y. Mechanism of Protein Stabilization by Trehalose during Freeze-Drying Analyzed by In Situ Micro-Raman Spectroscopy. J. Pharm. Sci. 2013, 102, 2484–2494. [Google Scholar] [CrossRef] [PubMed]
  107. Honda, Y.; Tanaka, M.; Honda, S. Trehalose extends longevity in the nematode Caenorhabditis elegans. Aging Cell 2010, 9, 558–569. [Google Scholar] [CrossRef] [PubMed]
  108. Purvis, J.E.; Yomano, L.P.; Ingram, L.O. Enhanced Trehalose Production Improves Growth of Escherichia coli under Osmotic Stress. Appl. Environ. Microbiol. 2005, 71, 3761–3769. [Google Scholar] [CrossRef] [Green Version]
  109. Rasulova, M.; Zečić, A.; Monje Moreno, J.M.; Vandemeulebroucke, L.; Dhondt, I.; Braeckman, B.P. Elevated Trehalose Levels in C. elegans daf-2 Mutants Increase Stress Resistance, Not Lifespan. Metabolites 2021, 11, 105. [Google Scholar] [CrossRef]
  110. McElwee, J.J.; Schuster, E.; Blanc, E.; Thornton, J.; Gems, D. Diapause-associated metabolic traits reiterated in long-lived daf-2 mutants in the nematode Caenorhabditis elegans. Mech. Ageing Dev. 2006, 127, 458–472. [Google Scholar] [CrossRef]
  111. Seo, Y.; Kingsley, S.; Walker, G.; Mondoux, M.A.; Tissenbaum, H.A. Metabolic shift from glycogen to trehalose promotes lifespan and healthspan in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 2018, 115, E2791–E2800. [Google Scholar] [CrossRef] [Green Version]
  112. Tauffenberger, A.; Fiumelli, H.; Almustafa, S.; Magistretti, P.J. Lactate and pyruvate promote oxidative stress resistance through hormetic ROS signaling. Cell Death Dis. 2019, 10, 653. [Google Scholar] [CrossRef]
  113. López-Otín, C.; Blasco, M.A.; Partridge, L.; Serrano, M.; Kroemer, G. The hallmarks of aging. Cell 2013, 153, 1194–1217. [Google Scholar] [CrossRef] [Green Version]
  114. de la Cruz-Ruiz, P.; Hernando-Rodríguez, B.; Pérez-Jiménez, M.M.; Rodríguez-Palero, M.J.; Martínez-Bueno, M.D.; Pla, A.; Artal-Sanz, M. Prohibitin depletion extends lifespan of a TORC2/SGK-1 mutant through autophagy and the mitochondrial UPR. Aging Cell 2021, 20, e13359. [Google Scholar]
  115. Van Gilst, M.R.; Hadjivassiliou, H.; Jolly, A.; Yamamoto, K.R. Nuclear Hormone Receptor NHR-49 Controls Fat Consumption and Fatty Acid Composition in C. elegans. PLoS Biol. 2005, 3, e53. [Google Scholar] [CrossRef] [Green Version]
  116. Wu, D.; Jian, C.; Peng, Q.; Hou, T.; Wu, K.; Shang, B.; Zhao, M.; Wang, Y.; Zheng, W.; Ma, Q.; et al. Prohibitin 2 deficiency impairs cardiac fatty acid oxidation and causes heart failure. Cell Death Dis. 2020, 11, 181. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  117. Sornda, T.; Ezcurra, M.; Kern, C.; Galimov, E.R.; Au, C.; de la Guardia, Y.; Gems, D. Production of YP170 vitellogenins promotes intestinal senescence in C. elegans. J. Gerontol. A Biol. Sci. Med. Sci. 2019, 74, 1180–1188. [Google Scholar] [CrossRef] [PubMed]
  118. Apfeld, J.; O’Connor, G.; McDonagh, T.; Distefano, P.S.; Curtis, R. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev. 2004, 18, 3004–3009. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  119. Schulz, T.; Zarse, K.; Voigt, A.; Urban, N.; Birringer, M.; Ristow, M. Glucose Restriction Extends Caenorhabditis elegans Life Span by Inducing Mitochondrial Respiration and Increasing Oxidative Stress. Cell Metab. 2007, 6, 280–293. [Google Scholar] [CrossRef] [Green Version]
  120. Kasashima, K.; Sumitani, M.; Satoh, M.; Endo, H. Human prohibitin 1 maintains the organization and stability of the mitochondrial nucleoids. Exp. Cell Res. 2008, 314, 988–996. [Google Scholar] [CrossRef] [PubMed]
  121. Jian, C.; Xu, F.; Hou, T.; Sun, T.; Jinghang, L.; Cheng, H.; Wang, X. Deficiency of PHB complex impairs respiratory supercomplex formation and activates mitochondrial flashes. J. Cell Sci. 2017, 130, 2620–2630. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  122. Strub, G.M.; Paillard, M.; Liang, J.; Gomez, L.; Allegood, J.C.; Hait, N.C.; Maceyka, M.; Price, M.M.; Chen, Q.; Simpson, D.C.; et al. Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. FASEB J. 2010, 25, 600–612. [Google Scholar] [CrossRef] [Green Version]
  123. Antonny, B.; Vanni, S.; Shindou, H.; Ferreira, T. From zero to six double bonds: Phospholipid unsaturation and organelle function. Trends Cell Biol. 2015, 25, 427–436. [Google Scholar] [CrossRef] [PubMed]
  124. van Meer, G.; Voelker, D.R.; Feigenson, G.W. Membrane lipids: Where they are and how they behave. Nat. Rev. Mol. Cell Biol. 2008, 9, 112–124. [Google Scholar] [CrossRef] [PubMed]
  125. Johnson, A.A.; Stolzing, A. The role of lipid metabolism in aging, lifespan regulation, and age-related disease. Aging Cell 2019, 18, e13048. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  126. Weir, H.J.; Yao, P.; Huynh, F.; Escoubas, C.C.; Goncalves, R.L.; Burkewitz, K.; Laboy, R.; Hirschey, M.; Mair, W.B. Dietary Restriction and AMPK Increase Lifespan via Mitochondrial Network and Peroxisome Remodeling. Cell Metab. 2017, 26, 884–896.e5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Metabolic rewiring in PHB-mediated ageing regulation. The PHB complex modulates mitochondrial membrane lipid composition, presumably by altering the balance of PL, leading to deregulation of mitochondrial function, including oxidative phosphorylation (OXPHOS). Mitochondrial dysfunction affects amino acid and carbohydrate metabolism in an IIS dependent-manner. Concomitantly, mitochondrial dysfunction reverberates, in an IIS-dependent manner, in other organelles such as yolk, lipid droplets, and the endoplasmic reticulum, leading to opposing ageing phenotypes.
Figure 1. Metabolic rewiring in PHB-mediated ageing regulation. The PHB complex modulates mitochondrial membrane lipid composition, presumably by altering the balance of PL, leading to deregulation of mitochondrial function, including oxidative phosphorylation (OXPHOS). Mitochondrial dysfunction affects amino acid and carbohydrate metabolism in an IIS dependent-manner. Concomitantly, mitochondrial dysfunction reverberates, in an IIS-dependent manner, in other organelles such as yolk, lipid droplets, and the endoplasmic reticulum, leading to opposing ageing phenotypes.
Metabolites 11 00636 g001
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Lourenço, A.B.; Artal-Sanz, M. The Mitochondrial Prohibitin (PHB) Complex in C. elegans Metabolism and Ageing Regulation. Metabolites 2021, 11, 636. https://doi.org/10.3390/metabo11090636

AMA Style

Lourenço AB, Artal-Sanz M. The Mitochondrial Prohibitin (PHB) Complex in C. elegans Metabolism and Ageing Regulation. Metabolites. 2021; 11(9):636. https://doi.org/10.3390/metabo11090636

Chicago/Turabian Style

Lourenço, Artur B., and Marta Artal-Sanz. 2021. "The Mitochondrial Prohibitin (PHB) Complex in C. elegans Metabolism and Ageing Regulation" Metabolites 11, no. 9: 636. https://doi.org/10.3390/metabo11090636

APA Style

Lourenço, A. B., & Artal-Sanz, M. (2021). The Mitochondrial Prohibitin (PHB) Complex in C. elegans Metabolism and Ageing Regulation. Metabolites, 11(9), 636. https://doi.org/10.3390/metabo11090636

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop